NPASS Compound

Natural Product: NPC27209

Natural Product ID	NPC27209
Common Name ? The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.	MOZIKWXTNVWDAB-JPNWVCBHSA-N
IUPAC Name	n.a.
Synonyms
Synthetic Gene Cluster	n.a.
ChEMBL Identifier	n.a.
PubChem CID	3086041
Chemical Classification	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000012] Lipids and lipid-like molecules [CHEMONTID:0000258] Steroids and steroid derivatives [CHEMONTID:0001445] Bile acids, alcohols and derivatives [CHEMONTID:0001124] Glycinated bile acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

Chemical Representations

RDKit 3D 73 76 0 0 0 0 0 0 0 0999 V2000 2.8775 -0.9489 2.5503 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7532 -1.3294 1.1136 C 0 0 2 0 0 0 0 0 0 0 0 0 4.0983 -1.0971 0.4580 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5401 0.3558 0.5522 C 0 0 0 0 0 0 0 0 0 0 0 0 5.8590 0.4850 -0.1090 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0112 1.2679 -1.1122 N 0 0 0 0 0 0 0 0 0 0 0 0 7.2889 1.3876 -1.7460 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6962 0.1135 -2.4257 C 0 0 0 0 0 0 0 0 0 0 0 0 8.7863 0.0636 -3.0211 O 0 0 0 0 0 0 0 0 0 0 0 0 6.8270 -0.9623 -2.3573 O 0 0 0 0 0 0 0 0 0 0 0 0 6.9474 -0.2372 0.3460 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7152 -0.6907 0.3231 C 0 0 1 0 0 0 0 0 0 0 0 0 1.7692 -1.2235 -1.0977 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3083 -1.3600 -1.5600 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3668 -0.4908 -0.5944 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.8209 -0.5339 -0.4516 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.1422 0.6630 0.4635 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.5405 0.4595 1.8105 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1982 -0.1255 1.8681 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2839 -0.9233 0.7296 C 0 0 2 0 0 0 0 0 0 0 0 0 0.1300 -2.4190 0.9393 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6042 0.9570 0.5309 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.1353 1.1077 1.9330 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8741 2.2099 -0.2686 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.2831 2.5729 -0.4378 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.3111 1.5308 -0.3024 C 0 0 2 0 0 0 0 0 0 0 0 0 -5.8655 0.1806 0.1112 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.4325 -0.1446 -0.1282 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.0775 -0.2701 -1.5958 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6011 -0.3817 -1.6761 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0656 -0.3445 -2.7590 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.0220 1.3748 -1.5189 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1553 -1.4982 3.2133 H 0 0 0 0 0 0 0 0 0 0 0 0 2.8518 0.1180 2.7590 H 0 0 0 0 0 0 0 0 0 0 0 0 3.8873 -1.3127 2.8980 H 0 0 0 0 0 0 0 0 0 0 0 0 2.6163 -2.4508 1.0916 H 0 0 0 0 0 0 0 0 0 0 0 0 4.8749 -1.7801 0.8584 H 0 0 0 0 0 0 0 0 0 0 0 0 4.0134 -1.3155 -0.6260 H 0 0 0 0 0 0 0 0 0 0 0 0 4.6540 0.6887 1.5937 H 0 0 0 0 0 0 0 0 0 0 0 0 3.7825 0.9958 0.0780 H 0 0 0 0 0 0 0 0 0 0 0 0 7.2082 2.2022 -2.5193 H 0 0 0 0 0 0 0 0 0 0 0 0 8.0474 1.6817 -0.9854 H 0 0 0 0 0 0 0 0 0 0 0 0 7.1507 -1.8834 -2.6211 H 0 0 0 0 0 0 0 0 0 0 0 0 7.9112 -0.0302 0.1150 H 0 0 0 0 0 0 0 0 0 0 0 0 1.8501 0.4287 0.3267 H 0 0 0 0 0 0 0 0 0 0 0 0 2.2648 -2.2158 -1.1427 H 0 0 0 0 0 0 0 0 0 0 0 0 2.2263 -0.4743 -1.7757 H 0 0 0 0 0 0 0 0 0 0 0 0 0.0511 -2.4197 -1.5337 H 0 0 0 0 0 0 0 0 0 0 0 0 0.2156 -1.0360 -2.6271 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.0238 0.5531 -0.7451 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.2346 -1.4074 0.0971 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.5755 1.5183 -0.0137 H 0 0 0 0 0 0 0 0 0 0 0 0 -2.2930 -0.1081 2.4270 H 0 0 0 0 0 0 0 0 0 0 0 0 -1.5035 1.4758 2.3065 H 0 0 0 0 0 0 0 0 0 0 0 0 0.5844 0.6596 2.0921 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.1615 -0.7857 2.7877 H 0 0 0 0 0 0 0 0 0 0 0 0 0.2763 -2.6894 2.0009 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.8730 -2.7990 0.6650 H 0 0 0 0 0 0 0 0 0 0 0 0 0.8355 -2.9848 0.2622 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.1048 1.6802 1.8421 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.5062 1.6923 2.6012 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.3490 0.1347 2.4119 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.2662 3.0218 0.2249 H 0 0 0 0 0 0 0 0 0 0 0 0 -3.3471 2.0515 -1.2551 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.5149 3.4095 0.2896 H 0 0 0 0 0 0 0 0 0 0 0 0 -5.3941 3.0836 -1.4424 H 0 0 0 0 0 0 0 0 0 0 0 0 -7.1201 1.8418 0.4266 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.0601 -0.0054 1.2087 H 0 0 0 0 0 0 0 0 0 0 0 0 -6.4701 -0.6308 -0.3939 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.2371 -1.1380 0.3551 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.5919 -1.1870 -1.9620 H 0 0 0 0 0 0 0 0 0 0 0 0 -4.4333 0.5906 -2.1799 H 0 0 0 0 0 0 0 0 0 0 0 0 -7.9487 1.0770 -1.3509 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 1 0 4 5 1 0 5 6 2 3 6 7 1 0 7 8 1 0 8 9 2 0 8 10 1 0 5 11 1 0 2 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 1 1 17 22 1 0 22 23 1 1 22 24 1 0 24 25 1 0 25 26 1 0 26 27 1 0 27 28 1 0 28 29 1 0 29 30 1 0 30 31 2 0 26 32 1 0 20 12 1 0 28 22 1 0 20 15 1 0 30 16 1 0 1 33 1 0 1 34 1 0 1 35 1 0 2 36 1 1 3 37 1 0 3 38 1 0 4 39 1 0 4 40 1 0 7 41 1 0 7 42 1 0 10 43 1 0 11 44 1 0 12 45 1 6 13 46 1 0 13 47 1 0 14 48 1 0 14 49 1 0 15 50 1 6 16 51 1 1 17 52 1 6 18 53 1 0 18 54 1 0 19 55 1 0 19 56 1 0 21 57 1 0 21 58 1 0 21 59 1 0 23 60 1 0 23 61 1 0 23 62 1 0 24 63 1 0 24 64 1 0 25 65 1 0 25 66 1 0 26 67 1 1 27 68 1 0 27 69 1 0 28 70 1 1 29 71 1 0 29 72 1 0 32 73 1 0 M END

Standard InCHIKey	MOZIKWXTNVWDAB-JPNWVCBHSA-N
Standard InCHI	InChI=1S/C26H41NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-20,24,28H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,24+,25+,26-/m1/s1
SMILES	C[C@H](CCC(=NCC(=O)O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@@]1(C)CC[C@H](C[C@H]1CC3=O)O

Calculated Properties

Physi-Chem Properties

Molecular Weight:	447.3	Volume:	471.065 ? Van der Waals volume.
Dense:	0.95	LogP:	4.563 ? The logarithm of the n-octanol/water distribution coefficients.
logD7.4:	3.647 ? The logarithm of the n-octanol/water distribution coefficient at pH=7.4.	LogS:	-4.244 ? The logarithm of aqueous solubility value.
Rotatable Bonds:	6.0	Rigid Bonds:	23.0
TPSA:	107.19 ? Topological Polar Surface Area.	H-Bond Acceptor:	6.0
H-Bond Donor:	3.0	Rings:	4.0
Heavy Atoms:	6.0

MedChem Properties

QED Drug-Likeness Score:	0.406	GASA:	1.0 ? GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:	4.763	Fsp³:	0.885
MCE-18:	74.286 ? MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.	Lipinski Rule-of-5:	Rejected
Pfizer Rule:	Rejected	GSK Rule:	Accepted
Golden Triangle Rule:	Rejected	BMS Rule:	0
Chelating Alert:	0	PAINS Alert:	0
Colloidal aggregators:	0.558	Fluc inhibitor:	0.0 ? The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:	0.015 ? The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1	Green fluorescence:	0.0 ? The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:	0.012	Promiscuous compounds:	0.776

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:	-5.518	MDCK Permeability:	-5.233
Pgp-inhibitor:	0.0	Pgp-substrate:	0.001
PAMPA:	0.884 ? The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).	Human Intestinal Absorption (HIA):	0.0
20% Bioavailability (F20%):	0.013	30% Bioavailability (F30%):	0.018
50% Bioavailability (F50%):	0.457

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.022	MRP1:	0.928
Plasma Protein Binding (PPB):	57.053%	Volume Distribution (VD):	-0.461
Fu:	42.819% ? The fraction unbound in plasms.	OATP1B1 inhibitor:	0.998
OATP1B3 inhibitor:	1.0	BCRP inhibitor:	0.009
BSEP inhibitor:	0.674

ADMET: Metabolism

CYP1A2-inhibitor:	0.0	CYP1A2-substrate:	0.0
CYP2C19-inhibitor:	0.001	CYP2C19-substrate:	0.0
CYP2C9-inhibitor:	0.0	CYP2C9-substrate:	0.0
CYP2D6-inhibitor:	0.0	CYP2D6-substrate:	0.0
CYP3A4-inhibitor:	1.0	CYP3A4-substrate:	1.0
CYP2B6-substrate:	0.0	CYP2C8-inhibitor:	0.998
HLM stability:	0.027 ? Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):

1.345

Half-life (T1/2):

1.672

ADMET: Toxicity

hERG Blockers:	0.033	hERG Blockers (10um):	0.032
Human Hepatotoxicity (H-HT):	0.834	Drug-induced Liver Injury (DILI):	0.881
AMES Toxicity:	0.325	Rat Oral Acute Toxicity:	0.422
Maximum Recommended Daily Dose:	0.458	Skin Sensitization:	0.999
Carcinogencity:	0.911	Eye Corrosion:	0.0
Eye Irritation:	0.557	Respiratory Toxicity:	0.846
Drug-induced Neurotoxicity:	0.102	Ototoxicity:	0.646
Hematotoxicity:	0.614	Drug-induced Nephrotoxicity:	0.887
Genotoxicity:	0.849	RPMI-8226 Immunitoxicity:	0.016
A549 Cytotoxicity:	0.034	Hek293 Cytotoxicity:	0.179
BCF:	0.353 ? Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].	IGC50:	3.046 ? 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:	4.318 ? 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].	LC50FM:	3.594 ? 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO13553	Silene coronaria	Species	Caryophyllaceae	Eukaryota	n.a.	n.a.	n.a.	Database[TCMID]
NPO6261	Calea serrata	Species	Asteraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO13424	Orthopappus angustifolius	Species	Asteraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO13553	Silene coronaria	Species	Caryophyllaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO5053	Myocastor coypus	Species	Myocastoridae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO28274	Cadra cautella	Species	Pyralidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	Organism Name	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Activity Type	# Activity
Ki	2

Activity Type	# Activity
Individual protein	2

Molecular-level activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference
NPT748	Individual protein	Bile acid transporter	Homo sapiens	Ki	=	4210.0	nM	PMID[31830636]
NPT754	Individual protein	Ileal bile acid transporter	Homo sapiens	Ki	=	20400.0	nM	PMID[31830636]

In vitro activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

In vivo activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

Experimental ADME

Experiment Model	Experiment Tissue	ADME Type	ADME Relation	ADME Value	ADME Unit	Reference

Experimental Toxicity

Quantitative toxicity

Experiment Model	Experiment Organism	Toxicity Type	Toxicity Relation	Toxicity Value	Toxicity Unit	Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity	Carcinogenicity	Mutagenicity	Cardiotoxicity	Respiratory Toxicity	Eye Irritation	Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]

Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

● The left chart: Distribution of similarity level between NPC27209 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	20814
0.1-0.2	25665
0.2-0.3	3181
0.3-0.4	163
0.4-0.5	21
0.5-0.6	8
0.6-0.7	3
0.7-0.8	0
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Natural Product ID
0.7541	Intermediate Similarity	NPC323180
0.7419	Intermediate Similarity	NPC270957
0.7419	Intermediate Similarity	NPC119633
0.6935	Remote Similarity	NPC185465
0.6324	Remote Similarity	NPC175419
0.6232	Remote Similarity	NPC171698
0.5493	Remote Similarity	NPC320478
0.5342	Remote Similarity	NPC133995
0.5342	Remote Similarity	NPC247891
0.5147	Remote Similarity	NPC608690
0.5139	Remote Similarity	NPC323958
0.5077	Remote Similarity	NPC133922
0.5075	Remote Similarity	NPC167702
0.5075	Remote Similarity	NPC280026

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC27209 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

range	Tanimoto Coefficient
0-0.1	5597
0.1-0.2	3351
0.2-0.3	174
0.3-0.4	18
0.4-0.5	8
0.5-0.6	2
0.6-0.7	0
0.7-0.8	0
0.8-0.85	0
0.85-0.9	0
0.9-0.95	0
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage
0.5342	Remote Similarity	NPD6700	Phase 4
0.5075	Remote Similarity	NPD6113	Clinical (unspecified phase)

Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data